Implementation of a pharmacist-run telephonic insulin titration service

Journal of the American Pharmacists Association

Volumn 52, Issue 6, 2012, Pages

  Weidman Evans, Emily ^a,b   Evans, Jeffery ^a,b   Eastwood, Robert ^b   Fort, Ashley ^b  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Diabetes; Insulin titration; Pharmacist interventions; Telephone consults

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ARTICLE; BLOOD GLUCOSE MONITORING; CONSULTATION; DIABETES MELLITUS; DRUG DOSE TITRATION; ELECTRONIC MEDICAL RECORD; FOLLOW UP; GLUCOSE BLOOD LEVEL; HOSPITAL DEPARTMENT; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MEDICATION THERAPY MANAGEMENT; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT PARTICIPATION; PATIENT REFERRAL; PHARMACIST; PHYSICIAN ASSISTANT; PRIMARY MEDICAL CARE; RESIDENT; TELEHEALTH; TELEPHONIC INSULIN TITRATION SERVICE;

EID: 84890922300     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2012.11225     Document Type: Article

References (18)

1. Selvin E, Mannopoulos S, Berdenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;141:421-31.
2. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545-59.
3. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560-72.
4. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in American veterans with type 2 diabetes. N Engl J Med. 2009;361:1024-5.
5. American Diabetes Association. Standards of medical care in diabetes: 2010. Diabetes Care. 2010;33(suppl S1): S11-61.
6. Kennedy L, Herman WH, Strange P, et al. Impact of active versus usual algorithmic titration of basal insulin and points-of-care versus laboratory measurement of HbA1C on glycemic control in patients with type 2 diabetes. Diabetes Care. 2006;29:1-8.
7. Blonde L. Merilainen M, Darwe V, Raskin P; TITRATE Study Group. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE Study. Diabetes Obes Metab. 2009;11:623-31.
8. Polonsky WH, Fisher L, Guzman S, et al. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care. 2005;28:2543-5.
9. Swinnen SGHA, DeVries JH. Contact frequency determines outcome of basal insulin initiation trials in type 2 diabetes. Diabetologia. 2009;52:2324-7.
10. Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28:421-36.
11. Nkansah NT, Brewer JM, Connors R, Shermock KM. Clinical outcomes of patients with diabetes mellitus receiving medication management by pharmacists in an urban private physician practice. Am J Health Syst Pharm. 2008;65:145-9.
12. McCord AD. Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service. Pharmacotherapy. 2006;26:248-53.
13. Kiel PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother. 2005;39:1828-32.
14. Rosenstock J, Davies M, Home PD, et al. A randomized, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naïve people with type 2 diabetes. Diabetologia. 2008;51:408-16.
15. Fogelfeld L, Dharmalingam M, Robling K, et al. A randomized, treat-to-target trial comparing insulin lispro protamine suspension and insulin detemir in insulin-naïve patients with type 2 diabetes. Diabet Med. 2010;27:181-8.
16. Rochester CD, Leon N, Dombrowski R, Haines ST. Collaborative drug therapy management for initiating and adjusting insulin therapy in patients with type 2 diabetes mellitus. Am J Health Syst Pharm. 2010;67:42-8.
17. Coast-Senior EA, Kroner BA, Kelley CL, Trilli LE. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother. 1998;32:636-41.
18. Ragucci KR, Fermo JD, Wessell AM, Chumney EC. Effectiveness of pharmacist-administered diabetes mellitus education and management services. Pharmacotherapy. 2005;25:1809-16.